OBR Daily Commentary

forumImage

Benefit of LDR Brachytherapy In Patients With Early-Stage Prostate Cancer Is Still Unclear

(IQWIG [Germany]) Nov 16, 2018 - Interstitial brachytherapy uses slightly radioactive particles implanted into the prostate to deliver radiation directly to the tumour (low-dose-rate, LDR). Due to a lack of conclusive data, it still remains an unresolved issue as to whether this procedure has advantages compared with other treatments in men with localized prostate cancer.

Read Article arrow

Tomasz M. Beer, MD, FACP (Posted: November 19, 2018)

quotesThe prostate cancer clinical and research community had fallen short when it comes to conducting basic trials that answer important questions about competing treatment options for localized disease. We really need to look in the mirror and ask ourselves why is it that treatment modalities that have been clinically available for decades still don't have a solid randomized trial to back them up. quotes

Add Comment 2 Comment
forumImage

Surgery & Combination Therapy Optimizes Results In Aggressive Prostate Cancer Management

(Science Magazine) Nov 17, 2018 - Results published in JAMA Oncology suggest post-operative radiation and hormone therapy, before cancer recurrence, as a new prostate cancer treatment option for men with a Gleason Score of 9 or 10.

Read Article arrow

Tomasz M. Beer, MD, FACP (Posted: November 19, 2018)

quotesWhile this study does not represent level I evidence, the message is consistent with that of other clinical trials: at the same time that we de-escalate treatment for men with low risk prostate cancer (where over-treatment is a major concern), those with highest risk features likely need maximum therapy with multiple modalities. quotes

Add Comment 1 Comment
forumImage

Cancer Hospital Ads Deceive Patients About Their Chances Of Survival, New Report Finds

(BuzzFeed News) Oct 25, 2018 - The Cancer Treatment Centers of America and other large cancer hospitals spend millions on marketing that is often misleading, according to a scathing new report.

Read Article arrow

Tomasz M. Beer, MD, FACP (Posted: October 26, 2018)

quotesCancer hospital ads deserve at least the same scrutiny as other advertising, where deceptive marketing is not OK. Cancer patients are at vulnerable population and need accurate information that can serve as a basis for sound decision making. Anecdotes of exceptional outcomes - particularly when they are exceedingly rare - are not the way to inform patients about where they should get their care.quotes

Add Comment 1 Comment

Meet the Editorial Board

Prostate Cancer
member photo
Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical O...

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Ca...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Woo...

Radiation Oncology
member photo
Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Pr...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signa...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...